AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...
The hospital knew that not taking medications as prescribed following discharge is one of the major drivers of readmissions, so it knew it needed a way to proactively manage this risk and improve its ...
New Hampshire lawmakers are weighing a measure to funnel state funding to skilled nursing facilities that train employees as medication nursing assistants. The goal is to increase certifications for ...
Stereotaxis CEO David Fischel talks about what it takes to enter the medical device industry in this exclusive clip from the ...
“Arrive Health has primarily been focused on point-of-care price transparency, so we’ve built a network that can deliver real-time, patient-specific, moment-in-time pricing around medication into EHR ...
Artivion stock is outperforming the med-tech sector. Here's what investors need to know about the company and its potential ...
According to the Advanced Medical Technology Association, med tech is defined as “companies that develop, manufacture, and distribute the technologies, devices, equipment, diagnostic tests, and health ...
If 2016 was the year that med tech players bet big on emerging and exciting technologies, 2017 will be the year to buckle down, generate evidence of the new tech’s utility and find its niche in the ...
AngioDynamics’ Med Tech segment delivered its fifth consecutive quarter of double-digit growth, increasing 13.0% to $35.7 million. This growth was led by the Auryon peripheral atherectomy platform, ...
Q2 FY2026 earnings call recap: revenue up 8.8%, Auryon & NanoKnife growth, raised guidance, margin outlook and risks—read now.
GC Capital has acquired a majority stake in Med-Tech Resource. Med-Tech supplies EMTs, fire departments, police departments and the military with critical emergency medical supplies. Financial terms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results